Background-Immunoglobulin amyloid light-chain (AL)-related cardiac amyloidosis (CA) has a worse prognosis than either wild-type (ATTRwt) or mutant (ATTRm) transthyretin (TTR) CA. Detailed echocardiographic studies have been performed in AL amyloidosis but not in TTR amyloidosis and might give insight into this difference. We assessed cardiac structure and function and outcome in a large population of patients with CA and compared findings in TTR and AL-related disease. Methods and Results-We analyzed 172 patients with CA (AL amyloidosis, n=80; ATTRm, n=36; ATTRwt, n=56) by standard echocardiography and 2-dimensional speckle-tracking imaging-derived left ventricular (LV) longitudinal (LS), radial, and circumferential strains. Despite a preserved LV ejection fraction (55±12%), LS was severely impaired in CA.
T he systemic amyloidoses are a group of uncommon diseases characterized by extracellular deposition of fibrillar proteins that lead to loss of normal tissue architecture and function. 1 Cardiac amyloidosis (CA) is attributable to intramyocardial amyloid infiltration, which leads to a progressive increase of ventricular wall thickness and stiffness. 1, 2 The most frequent types of systemic amyloidosis associated with clinically relevant cardiac involvement include the following: (1) amyloid light-chain (AL) amyloidosis attributable to a clonal plasma cell dyscrasia, which produces the immunoglobulin light chain precursors of the fibrillary deposits; (2) the hereditary, transthyretin-related mutant form (ATTRm), which can be caused by >100 mutations of transthyretin (TTR), a transport protein mainly synthesized by the liver; and (3) wildtype (nonmutant) transthyretin-related amyloidosis (ATTRwt), which mainly affects the hearts of elderly men. 2, 3 Cardiac involvement is common and carries a negative prognosis in all pathogenetic subtypes. 2, 3 However, despite apparently similar degrees of myocardial infiltration as assessed by wall thickness, these diseases are characterized by different clinical courses. 3, 4 The severity of heart failure (HF) and survival are much worse in AL amyloidosis than in TTR-related amyloidoses, 3, 4 with a median survival of approximately 6 months in untreated AL amyloidosis with HF compared with 6 years in ATTRwt. 4 This finding has been partly attributed to a direct cardio-toxic effect of circulating immunoglobulin lights chains. 5 Although standard echocardiography remains the mainstay for the noninvasive diagnosis of CA, contemporary echocardiographic techniques, such as myocardial deformation imaging, have been proven to play an adjunctive role in the diagnosis and prognostic stratification of CA. 6 Specifically, strain and strain rate imaging parameters obtained by tissue Doppler imaging techniques and 2-dimensional (2D) speckle-tracking imaging (STI) have been shown to be significantly reduced in AL-related CA (both in advanced and asymptomatic heart involvement) when compared with unaffected controls and other causes of wall thickening (such as hypertensive heart disease and hypertrophic cardiomyopathy). 7, 8 Recently, reduced longitudinal strain (LS) in CA has been shown to have an unusual and typical pattern, with severe impairment of strain at the base and an "apical sparing" pattern that differentiates CA from other causes of true left ventricular (LV) hypertrophy. 9 Finally, LV longitudinal function has been proven to be an independent predictor of survival in AL amyloidosis. 10, 11 Given the markedly different prognoses in AL and TTR amyloidoses with cardiac involvement, there may be differences in the echocardiographic profiles of the diseases. However, because all of the previous larger studies of strain imaging have been performed in AL amyloidosis, it is not clear whether similar findings are seen in the TTR-related forms of CA. Therefore, we compared the echocardiographic (both conventional and 2D STI) and outcome profiles of ATTRm and ATTRwt with a group of patients with AL amyloidosis to define the features of TTR amyloidosis and, through comparative analysis, to determine whether any observed differences might account for the very different prognoses between AL and TTR CA.
Methods

Setting and Study Design
We conducted a multicenter longitudinal study of patients with pathogenetically defined CA, based on data pooled from 2 large international centers providing facilities for the diagnosis and treatment of systemic amyloidosis. All consecutive patients diagnosed with CA who underwent echocardiographic evaluation at the Brigham and Women's Hospital (Boston, MA) from 2006 to 2012 or at the S. Orsola-Malpighi Hospital (Bologna, Italy) from 2009 to 2012 were included in the analysis.
We compared ATTRwt, ATTRm, and AL-related CA in terms of clinical/instrumental profiles at the time of their first evaluation and determined outcome. Analysis of echocardiograms was done by 2 investigators blinded to the pathogenesis of amyloidosis. After analysis, patients were divided into 3 groups based on the pathogenesis of amyloidosis (AL, ATTRm, or ATTRwt). At the Bologna center, all patients provided informed consent for anonymous publication of scientific data. At the Boston center, the collection of medical records was approved by the Institutional review board.
Diagnostic Definitions
For the diagnosis of systemic amyloidosis and the specific amyloid subtypes (AL amyloidosis, ATTRm, and ATTRwt), as well as for the definition of cardiac involvement, kidney involvement, peripheral nervous system involvement, autonomic impairment, and disease duration, we referred to the standard diagnostic criteria. 2, 3, [12] [13] [14] [15] [16] [17] [18] A detailed list of diagnostic definitions, along with the definition of cardiovascular comorbidities, is reported in the online-only Data Supplement.
Cardiac Evaluation
All patients had an initial diagnostic assessment that included clinical evaluation, ECG, echocardiogram, and biochemical evaluation. Twelve-lead electrocardiograms, performed at the time of echocardiography, were reviewed for rhythm disturbances and the presence of low-voltage pattern (QRS amplitude ≤0.5 mV in all limb leads or ≤1 mV in all precordial leads). Voltage/mass ratio was calculated as Sokolow index divided by the cross-sectional area of the LV wall with the formula defined by Carroll et al. 19 Echocardiograms were performed at both centers using commercially available ultrasound systems (iE33, Philips Medical Systems; and Vivid 7, GE Medical Systems, Milwaukee, WI). Analysis of the echocardiographic images (both conventional and STI measurements) was conducted at the cardiac imaging core laboratory of the Brigham and Women's Hospital. Views of the heart were obtained from the parasternal, apical, and subcostal positions. A summary of conventional echocardiographic variables analyzed in the study and their definitions is reported in the online-only Data Supplement. [20] [21] [22] [23] [24] 
2D STI
For offline 2D STI, digitally acquired echocardiographic images in DICOM (Digital Imaging and Communications in Medicine) format with acceptable image quality were uploaded to the vendor-independent offline 2D Cardiac Performance Analysis software (TomTec Imaging Systems, Munich, Germany). These methods have been validated with magnetic resonance imaging and sonomicrometry and have been proven to be highly reproducible. 25, 26 Non-acceptable image quality was defined as lack of a full cardiac cycle, >1 segment dropout, digital format other than DICOM, missing view, or significant foreshortening of the left ventricle. The endocardial border was traced at an end-diastolic frame in apical views and at an end-systolic frame in short-axis views. End-diastole was defined by the QRS complex or by the frame just before mitral valve opening. The software tracked speckles along the endocardial and epicardial borders throughout the cardiac cycle. Peak LS, radial strain (RS), and circumferential strain values were computed automatically, generating regional data from 6 segments and an average value for each view.
Peak average LS and RS values were measured in the apical 4-chamber and apical 2-chamber views and averaged, whereas peak circumferential strain was measured in the midpapillary level short-axis view. Abnormality of LS, RS, and circumferential strain values was defined based on published data in healthy subjects. 27 Interobserver and intraobserver variability was assessed for LS in a sample of 20 randomly selected patients. The coefficient of variation for interobserver variability was 4.9%, with an intraclass correlation coefficient of 0.99 (95% CI=0.98-1.00). The coefficient of variation for intraobserver variability was 6.3%, with an intraclass correlation coefficient of 0.97 (95% CI=0.94-1.00).
Follow-Up
In both centers, follow-up visits were planned for every 6 months (or more frequently if clinically appropriate). Follow-up was closed in May 2013; for patients who had not attended a visit in the last 6 months, vital status was ascertained by telephone or by contacting referring physicians.
Statistical Analysis
Summary statistics are expressed as mean±SD/median (interquartile range) or numbers (percentages). In contingency tables, independence of categorical variables was tested using Fisher's exact test or Pearson's χ 2 test (according to Cochran's rule). Independence of continuous variables was tested using 1-way ANOVA or Kruskal-Wallis test in case of normally or not normally distributed variables, respectively. For multiple comparisons, we calculated Bonferroni-corrected P values. Comparisons of echocardiographic parameters were also adjusted for a priori selected demographic, clinical, and laboratory covariates, using ANOVA, logistic, or ordered logistic regression models.
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Spearman's rank correlation coefficient (ρ) was used to study the association between LS and LV ejection fraction, LV mean wall thickness, and E-wave deceleration time, both in the overall population and among the different causes. We tested a priori selected variables chosen for their potential clinical relevance in a series of multivariable models constructed to assess their association with parameters of systolic and diastolic function. Skewed variables were log-transformed. Multivariable regression models were reported as β coefficient and 95% CI.
To assess whether clinical parameters or echocardiographic indices of cardiac function were associated with LV wall thickness, we categorized the overall population of patients with CA by tertiles of LV wall thickness and applied nonparametric tests for trend across ordered groups.
Overall survival and survival free from incident HF were analyzed with Kaplan-Meier curves. Survival was censored at the time of liver or combined heart-liver transplantation for ATTRm. To explore risk factors that could be associated with all-cause mortality and incident HF, univariate Cox regression analysis was initially performed using clinical and instrumental variables. Multivariable analysis was then performed by entering into the model a set of variables that were considered significant on univariate analysis (P<0.1) or on the basis of their potential clinical or pathophysiological relevance. We considered incident HF only if the event required hospitalization for intravenous vasoactive medications. Analyses were conducted using Stata 12 SE (StataCorp, College Station, TX). All tests were 2 sided, and a P value <0.05 was considered statistically significant. In the presence of highly correlated parameters, only 1 variable-selected based on Harrell's C coefficient-was included in the final model.
Results
Study Population
A total of 172 patients (62 patients first evaluated in Bologna, 110 seen in Boston) entered the analysis: 36 were affected by ATTRm, 56 were affected by ATTRwt, and 80 were affected by AL amyloidosis. AL amyloidosis mainly derived from the Boston center (55 of 80, 69%), as did patients with ATTRwt (43 of 56, 77%), whereas patients with ATTRm mainly derived from the Bologna center (24 of 36, 67%). Endomyocardial biopsy was performed in all patients with ATTRwt to confirm the diagnosis. Among patients with AL amyloidosis, endomyocardial biopsy was performed in 57 cases (71%). In the remaining cases, extracardiac biopsies were performed to confirm the diagnosis, including liver (3 cases), kidney (5 cases), and bone marrow (15 cases). Among patients with ATTRm, endomyocardial biopsy was performed in 26 cases (72%). In all patients from the Bologna center, immunohistochemistry along with genotyping and serum/urine immunofixation was used to confirm the amyloid subtype. In only 2 cases in which immunohistochemistry was inconclusive was proteomics performed. Proteomics was performed in 6 cases from Boston. The TTR mutations were as follows: (1) Ile68Leu (n=10); (2) Glu89Gln (n=6); (3) Val122Ile (n=5); (4) Val30Met (n=4); (5) Thr60Ala (n=4); (6) Thr49Ala (n=2); (7) Arg34Thr (n=1); (8) Glu54Gln (n=1); (9) Gly47Ala (n=1); (10) Thr59Lys (n=1); and (11) Ala81Thr (n=1). Table 1 summarizes the main clinical findings in the overall population and according to the specific amyloid subtype. As anticipated, patients with ATTRwt were more likely to be elderly men with a higher prevalence of atrial fibrillation, as well as longer disease duration. Table 2 summarizes the main conventional echocardiographic findings in the overall population and in the different pathogenetic subgroups. Overall, CA was characterized by a symmetrical increase of LV wall thickness with nondilated ventricles, enlarged LA, preserved LV ejection fraction, and increased pulmonary pressures. Pericardial effusion coexisted in ?50% of cases. Despite preserved LV ejection fraction, the longitudinal systolic function evaluated by tissue Doppler imaging was considerably depressed when compared with normal reference values. 24 Diastolic function was abnormal in >80% of cases.
Echocardiographic Findings
28
2D STI variables in the overall population and in the different pathogenetic subgroups are listed in Table 3 . Both global LS and RS were significantly depressed in patients with CA compared with normal reference values, 27 whereas the circumferential strain was preserved. No major differences emerged in STI-derived parameters when comparing patients from the 2 centers (data not shown).
There was an inverse correlation between global LS and LV ejection fraction (r=−0.55, P<0.001), a weak positive correlation between global LS and LV mean wall thickness (r=0.34, P<0.001), and a weak inverse correlation between global LS and E-wave deceleration time (r=−0.39, P<0.001). ATTRm showed the highest correlation between global LS and both LV ejection fraction (r=−0.61, P<0.001) and mean LV wall thickness (r=0.56, P<0.001), whereas ATTRwt was associated with a higher correlation between LS and E-wave deceleration time (r=−0.43, P=0.009). Among patients with AL amyloidosis, we found a weak direct correlation between lambda light-chain values and E/A ratio (early/late ventricular filling velocity ratio; Spearman's ρ=0.44, P=0.002). No relations between light-chain (kappa or lambda) values and LV wall thickness, LV ejection fraction, or LV LS were observed. Figure 1 shows the frequency of abnormal indices of systolic and diastolic function in the overall population: 2D STI-derived parameters (global RS and LS) were more frequently impaired than conventional echocardiographic indices of systolic and diastolic function.
Patients with ATTRwt were more likely to display a higher degree of both morphological and functional impairment, as expressed by higher values of LV wall thickness and mass, left atrial size, and more depressed indices of systolic function, including LV ejection fraction, S′ (lateral mitral systolic velocity), stroke work, stroke volume, and cardiac output (Table 2) , even when adjusting for preexisting demographic/clinical differences. No major differences were apparent between causes in terms of E (early filling velocity), E/A ratio, and E/E′ ratio (mitral peak velocity of early filling/early diastolic mitral annular velocity ratio), as well as of the prevalence of the different grades of diastolic dysfunction.
LS values were least impaired in patients with ATTRm (Table 3) . Despite a lower LV mass and slightly higher LV ejection fraction when compared with patients with ATTRwt (Table 2) , patients with AL amyloidosis displayed similar degrees of depressed longitudinal and radial function ( Table 3) . As documented previously, 9 a pattern of apical sparing of LS was common, with preservation of apical strain in two thirds of cases. Apical strain was preserved regardless of the pathogenesis of CA (Table 3 ). Figure I in the online-only Data Supplement graphically highlights selected data from Table 3 , showing regional LS and RS function at basal, midventricular, and apical levels in the 3 causes of CA.
Interestingly, whereas almost all indices of systolic and diastolic function, including STI-derived strain, worsened with increasing tertiles of LV wall thickness (Table 4) , LS in the apex remained unchanged and within normal limits. 29 At multivariable analysis ( [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] months in ATTRwt). All patients with AL amyloidosis received chemotherapeutic agents, and 19 (24%) had high-dose chemotherapy with stem cell replacement, 2 of whom also received heart transplantation. Among patients with ATTRm, 4 (11%) underwent liver transplantation and 3 (8%) underwent combined heart/liver transplantation. One patient affected by ATTRwt underwent heart transplantation. During the study period, there were 57 (33%) deaths (35 among patients with AL amyloidosis, 7 among patients with ATTRm, and 15 among patients with ATTRwt), for a death rate of 6.9/100 person years among patients with AL amyloidosis, 2.04/100 person years among patients with ATTRm, and 3.4/100 person years among patients with ATTRwt. Hospitalizations for HF (occurring either at the time of the first evaluation or subsequently during the follow-up period) were recorded in 81 (47%) patients (39 AL, 18 ATTRm, and 24 ATTRwt), with an incidence rate of 10.3/100 person years among patients with AL, 4.9/100 person years among patients with ATTRm, and 4.8/100 person years among patients with ATTRwt. Figure 2 reports the overall unadjusted survival (A) and survival free from HF (B) according to the specific pathogenesis of CA. As expected, patients with AL amyloidosis fared worse than patients with ATTRwt and ATTRm (log-rank P value=0.002), whereas there were no statistical differences between the 3 causes when considering freedom from HF (log-rank P value=0.11; Figure 2 ). We did not observe any statistical difference in overall survival or survival free from incident HF between patients with AL amyloidosis with and without multiorgan involvement (log-rank P value=0.56 and 0.97, respectively). Table 6 reports the results of multivariable analysis. ATTRm and ATTRwt and estimated glomerular filtration rate were favorable predictors of overall survival, whereas severe HF (New York Heart Association class III to IV) and impaired global LV LS were unfavorable. When AL and TTR amyloidoses were analyzed separately, estimated glomerular filtration rate was the only still significant predictor of survival (hazard ratio: 0.98, 95%CI=0.97-0.99, P=0.029 in AL; hazard ratio: 0.96, 95% CI=0.93-0.99, P=0.06 in TTR amyloidoses). With regard to freedom from incident HF, none of the variables that were statistically related to the outcome at univariate analysis (including pathogenesis and LS) reached statistical significance at multivariable analysis.
Discussion
Our study, which includes the largest series so far of patients with TTR-related CA comprehensively studied by both conventional echocardiography and 2D STI, supports the role of myocardial deformation imaging as a sensitive tool for characterizing LV dysfunction in CA over more traditional echocardiographic parameters. Our findings provide insights into the pathophysiological mechanisms underlining LV dysfunction in amyloid heart disease, suggesting a role for specific pathogenesis and LV wall thickness in determining LV dysfunction. Along with pathogenesis, LV LS was found to be an independent predictor of overall survival, confirming the previously observed prognostic significance of strain in patients with AL amyloidosis.
CA is commonly considered a form of restrictive cardiomyopathy, and the pathophysiology of HF has traditionally been attributed to diastolic dysfunction. Only a few studies have assessed the individual contributions of systolic and diastolic dysfunction to the pathophysiology of LV dysfunction in CA. Most of the published data are based on conventional echocardiographic techniques and mainly address AL amyloidosis and to a much lesser extent the echocardiographic profiles of TTR CA. 3, 4, 30 Our study shows that, despite different pathophysiological backgrounds, AL amyloidosis and ATTRwt were characterized by similar degrees of impairment in LS and RS, whereas ATTRm had better functional parameters and, as expected, a better outcome. Apical LV segments were preserved independent of the specific pathogenesis of amyloidosis and the degree of LV wall thickening.
Myocardial deformation imaging is a sensitive method for the assessment of cardiac performance, and there is a growing interest in the use of strain imaging for the evaluation of patients with CA. 6 Previously published data have shown severe impairment of longitudinal function with apical preservation of myocardial strain. 7, 9 However, most of these studies were done with tissue Doppler imaging strain, which is subject to considerable interobserver and intraobserver variability and artifacts. 7, 10 Our study, using the more accurate STI, confirmed these earlier findings, supporting the role of myocardial deformation imaging as a sensitive tool for characterizing LV dysfunction in CA over more traditional echocardiographic parameters. Furthermore, because LS using either Doppler-derived indices or STI has been shown to be a marker of prognosis in AL CA, 7, 11 it is likely that STI will also be a robust technique for predicting prognosis in TTR amyloidosis.
Although it is recognized that patients with TTR-related CA have similar conventional echocardiographic appearances to AL amyloidosis, they have a markedly better prognosis. 30 Therefore, we anticipated that indices of myocardial deformation might be less impaired. Although patients with ATTRm showed better average values of LV strain than patients with AL, this difference was also present compared with patients with ATTRwt and may reflect less myocardial involvement, as suggested by the lower LV mass. More surprising was the finding in patients with ATTRwt: these patients showed a degree of myocardial dysfunction similar to the patients with AL, as well as a similar pattern of regional variability characterized by apical sparing of LS. Thus, the vastly different clinical course of these patient groups is unlikely to be due to differences in myocardial function, either systolic or diastolic. The explanation for this is unclear. Perhaps a longer history of myocardial amyloid deposition in ATTRwt might allow the development of local mechanisms, including some degree of LV hypertrophy, which might compensate for the effect of amyloid deposition. Alternatively, nonmyocardial cardiovascular factors, such as involvement of the autonomic nervous system control of the vasculature (known to be much more prevalent in AL amyloidosis) might play a role in the poor prognosis of cardiac AL amyloidosis. 31 Another possibility for the worse outcome in AL amyloidosis is the effect of cardiotoxic light chains, present in the active stage of AL amyloidosis. 5 The majority of the patients with AL in this study had active disease at the time of the echocardiogram and showed elevated lambda or kappa circulating light chains. The better outcome of ATTRwt amyloidosis and the absence of differences in strain values between patients with AL and ATTRwt do not preclude an effect of light-chain toxicity on cardiac function, because patients with ATTRwt tended to have a higher LV mass than patients with AL amyloidosis and more depressed indices of contractility (including stroke volume and work indexed, LV ejection fraction, cardiac output). Because increasing LV mass was associated with worsening indices of strain, it is possible that, in patients with AL amyloidosis (a rapidly progressive disease), LV longitudinal function gets impaired before other measures of LV contractility. This suggests that a toxic effect exerted by circulating light chains on longitudinal fibers (which are distributed in the subendocardial layers) occurs before the mass effect exerted by chronic amyloid deposition. The latter mechanism is more evident in ATTRwt.
Limitations
Although this study represents the largest series of patients with CA of the 3 main causes comprehensively characterized by means of both conventional and speckle-tracking echocardiography thus far, the absolute number of patients within each cause is relatively small. However, the findings in the 80 patients with AL amyloidosis are similar to those in somewhat larger series confined to AL amyloidosis, suggesting that the data from the ATTR group are also likely to be sound. The cross-sectional design of the study does not allow speculation on the natural history of amyloid infiltration in the heart. However, this was not the aim of the study, and our findings provide new insights into the functional abnormalities in TTR-related CA and suggest hypotheses concerning the nature of these abnormalities. Finally, the cases included in the present study generally had an advanced stage of the disease and therefore preclude insights into the earlier stages of CA disease.
Conclusions
This study of a large series of patients with CA highlights the role of speckle-tracking echocardiography in characterizing LV dysfunction in CA. Our analysis shows that, despite different pathophysiological backgrounds, TTR-related CA (particularly that attributable to wild-type TTR deposition) has a very similar pattern of myocardial deformation to AL amyloidosis, including the typical apical sparing pattern of regional strain. Although the degree of LV wall thickening seems to be an important determinant of LV LS, this relationship is less evident in AL amyloidosis, underscoring the possible importance of other contributors to the pathophysiology of LV dysfunction, such as the toxicity of circulating light chains.
As documented previously for AL amyloidosis, 10,11 strain imaging was confirmed to be related to prognosis in CA attributable to different causes, yet we showed that strain was equally impaired in both AL and ATTRwt amyloidoses. Because patients with ATTRwt amyloidosis have a much better prognosis than those with AL amyloidosis, 3, 4 our findings underscore the need to recognize the pathogenesis of amyloidosis when evaluating regional strain and highlight the importance of designing future large studies to determine the real contribution of regional strain impairment to prognosis in TTR amyloidosis (ATTRm or ATTRwt).
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